ClinicalTrials.gg

Program

desloratadine

Also written as “Desloratadine”, “Desloratadine 5 mg” and “Desloratadine 5 mg (Clarinex)”.

Its studies are mostly in Rhinitis, Allergic, Seasonal · Rhinitis, Allergic · Urticaria · Hypersensitivity · Chronic Urticaria, led by 6 companies.

Furthest: phase 4, since Apr 4, 200639 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Organon270 open or runningphase 4since Apr 4, 2006Apr 4, 2006none ahead
Dr. Reddy's Laboratories60 open or runningphase 1since Mar 11, 2011Mar 11, 2011none ahead
EMS30 open or runningphase 3since Feb 6, 2012Feb 6, 2012none ahead
Ache Laboratorios Farmaceuticos10 open or runningphase 3since Mar 8, 2016Mar 8, 2016none ahead
Eurofarma Laboratorios10 open or runningphase 3since Dec 13, 2021Dec 13, 2021none ahead
Laboratorios Silanes S.A. de C.V.10 open or runningphase 3since Apr 1, 2025Apr 1, 2025none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 20 studies since Apr 4, 2006.

  1. Jan 5, 2009Phase 3 study in Dermatitis, AtopicOrganon · NCT00817076 · 40 enrolled
  2. Jan 5, 2009Phase 2 study in Rhinitis, Allergic, SeasonalOrganon · NCT00816972 · 540 enrolled
  3. Mar 20, 2009Phase 4 study in Rhinitis, Allergic, SeasonalOrganon · NCT00867191 · 233 enrolled
  4. Mar 11, 2011Dr. Reddy's Laboratories's first studies: 2 phase 1 studiesNew to Dr. Reddy's LaboratoriesDr. Reddy's Laboratories · NCT01314352, NCT01314339
  5. Jun 10, 2011Phase 1 study in HealthyDr. Reddy's Laboratories · NCT01373138 · 34 enrolled · Canada
  6. Sep 27, 2011Phase 1 study in HealthyDr. Reddy's Laboratories · NCT01506791 · 44 enrolled · United States
  7. Jan 5, 20122 phase 1 studies in HealthyDr. Reddy's Laboratories · NCT01506050, NCT01506037
  8. Feb 6, 2012EMS's first studies: 2 phase 3 studiesNew to EMSEMS · NCT01529242, NCT01529229
  9. Oct 31, 2012Phase 3 study in Rhinitis, AllergicEMS · NCT01720485 · 234 enrolled · Brazil
  10. Aug 2, 20133 phase 3 studiesOrganon · NCT01916980, NCT01916967, NCT01918033
  11. Dec 15, 2014Phase 3 study in Rhinitis, Allergic, SeasonalOrganon · NCT02320396 · 449 enrolled
  12. Mar 8, 2016Ache Laboratorios Farmaceuticos's first study: phase 3 study in Common ColdNew to Ache Laboratorios FarmaceuticosAche Laboratorios Farmaceuticos · NCT02904304 · 150 enrolled · Brazil
  13. Dec 13, 2021Eurofarma Laboratorios's first study: phase 3 study in Rhinitis, AllergicNew to Eurofarma LaboratoriosEurofarma Laboratorios · NCT05214911 · 262 enrolled · Brazil
  14. Apr 1, 2025Laboratorios Silanes S.A. de C.V.'s first study: phase 3 study in Rhinitis, AllergicNew to Laboratorios Silanes S.A. de C.V.Laboratorios Silanes S.A. de C.V. · NCT06916884 · 70 enrolled · Mexico

TargetBeta

HRH1 →read by rule
“Histamine H1 receptor antagonist”ChEMBL 37, by rule

Other programs on HRH1

ProgramCompanyFurthest phaseStudies
fexofenadineruleSanofiphase 438
bilastinerulefaes-farma-s-aphase 419
DiphenhydramineruleJohnson & Johnsonphase 416

Studies

All 39 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT06916884Rhinitis, Allergic · Mexico3CompletedLaboratorios Silanes S.A. de C.V.Oct 15, 202570
NCT05214911Rhinitis, Allergic · Brazil3CompletedEurofarma LaboratoriosMar 23, 2025262
NCT02904304Common Cold · Brazil3SuspendedAche Laboratorios FarmaceuticosJul 2021150
NCT02320396Rhinitis, Allergic, Seasonal3CompletedOrganonApr 27, 2015449
NCT01918033Rhinitis, Allergic, Perennial3CompletedOrganonJan 26, 2014608
NCT01916980Eczema3CompletedOrganonMar 8, 201494
NCT01916967Urticaria3CompletedOrganonFeb 28, 2014239
NCT01720485Rhinitis, Allergic · Brazil3UNKNOWNEMSDec 2013234
NCT01529242Cutaneous Hypersensitivity · Brazil3TerminatedEMSAug 201617
NCT01529229Rhinitis, Allergic3CompletedEMSOct 2014210
NCT01506050Healthy · United States1CompletedDr. Reddy's Laboratories35
NCT01506037Healthy · United States1CompletedDr. Reddy's Laboratories36
NCT01506791Healthy · United States1CompletedDr. Reddy's Laboratories44
NCT01373138Healthy · Canada1CompletedDr. Reddy's Laboratories34
NCT01314352Lecithin Cholesterol Acyltransferase Deficiency · United States1CompletedDr. Reddy's LaboratoriesDec 200528
NCT01314339Fasting · United States1CompletedDr. Reddy's LaboratoriesDec 200528
NCT00867191Rhinitis, Allergic, Seasonal4CompletedOrganonApr 1, 2003233
NCT00817076Dermatitis, Atopic3CompletedOrganonJul 200340
NCT00816972Rhinitis, Allergic, Seasonal2CompletedOrganonJun 2005540
NCT00805584Rhinitis, Allergic, Seasonal4CompletedOrganonJun 2003311
NCT00805324Rhinitis, Allergic, Seasonal3CompletedOrganonAug 200354
NCT00795158Urticaria3CompletedOrganonJan 2004282
NCT00795522Urticaria4CompletedOrganonFeb 200551
NCT00794846Rhinitis, Allergic, Seasonal4CompletedOrganonMay 2003124
NCT00794794Rhinitis, Allergic3CompletedOrganonNov 2004204
NCT00794599Rhinitis, Allergic, Seasonal4CompletedOrganonAug 2003118
NCT00794495Rhinitis, Allergic, Seasonal4CompletedOrganonJul 2003122
NCT00794378Rhinitis, Allergic3CompletedOrganonNov 2004202
NCT00783354Urticaria4CompletedOrganonFeb 1, 2004129
NCT00783211Rhinitis, Allergic, Seasonal4CompletedOrganonOct 1, 2004722
NCT00783146Rhinitis, Allergic, Seasonal4CompletedOrganonOct 1, 2004728
NCT00780403Hypersensitivity4CompletedOrganonOct 2005220
NCT00779636Allergic Airway Disease4CompletedOrganonNov 1, 2004506
NCT00779116Hypersensitivity4CompletedOrganonOct 2005217
NCT00757562Chronic Urticaria3CompletedOrganonOct 1, 200397
NCT00751218Urticaria4CompletedOrganonMay 24, 2005174
NCT00751166Urticaria4TerminatedOrganonMay 1, 2005149
NCT00359138Hypersensitivity4CompletedOrganonMay 200636
NCT00311844Conjunctivitis, Allergic4CompletedOrganonMay 28, 200541

How it is read

Names in the registry

  • “Desloratadine”, 12 entries
  • “desloratadine”, 11 entries
  • “Desloratadine 5 mg”, 3 entries
  • “Desloratadine 5 mg (Clarinex)”, 3 entries
  • “Desloratadine + Prednisolone”, 3 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
desloratadine (Organon): development program | ClinicalTrials.gg